Corporate Relations: News and Opportunities

Registration for 2015 Lower Extremity Arterial Revascularization now open

Your company will engage with a motivated audience at LEARN exhibits and hands-on workshops. Learn more.

Corporate Ambassadors program: Value for IR

In the winter issue  of IR Quarterly, SIR Executive Director Sue Holzer talks about the Corporate Ambassador Program (CAP) as being …"predicated on the idea of creating value for IR together across the spectrum of education, advocacy, research, evidence building and engagement—areas where our corporate supporters clearly share SIR and SIR Foundation’s interest in advancement.” Read more …

Save the date – Y-90: The Complete Course is back in San Francisco, January 2016

Build valuable relationships with 150 IRs and faculty experts who have particular focus in IO. Features motivated learners in an intimate environment, with hands-on training opportunities. Check out this album from the 2015 Y90 course.

Hotel details will be provided at a later date.






Corporate Ambassador Program: A New Approach for Universal Support and Recognition of Corporate Partners in 2015

CAP is a high-impact, coordinated support and recognition program, designed for our coprorate partners who choose to invest in IR today and in the future through their support. Find out why your company should become a Corporate Ambassador, and how CAP helps advance our shared mission.

For additional information, please contact Beth Allgaier, SIR director of corporate relations, via email at or by phone at (703) 460-5564.

TouchPoints Corporate Newsletter

TouchPoints highlights critical opportunities for corporate engagement with SIR and SIR Foundation. Have feedback or want to receive TouchPoints? Contact Susie Evenden.

Update on SIR 2015 Fellows Spring Practicum

With the highest number of IR fellows ever, and a faculty comprised of 21 experts in the field, the success this year’s SIR Fellows Spring Practicum, May 14-16 in Chicago, was obvious to the 18 exhibiting companies and their personnel. Hands-on workshops featuring simulators and models helped train fellows in the latest device and techniques available, both in interventional oncology and PAD. Imaging and pain management was also highlighted at exhibits during the two-day course. We are grateful for the Corporate Ambassador Program (CAP) partners who help make the Practicum possible: Bard, Boston Scientific, BTG, Cook Medical, Cordis, Covidien, Endocare, Medtronic, McKesson, Penumbra, Siemens Healthcare, Sirtex and Stryker Interventional Spine. View a photo album from the Practicum.

IR Now a Specialty, 5 Year Residency Being Developed

ABMS approves dual primary certificate in interventional radiology and diagnostic radiology. Moving to a primary certificate, as opposed to a subspecialty certificate, designates interventional radiology as a unique and distinct area of medicine, rather than an area of focus within an existing specialty. Learn more on SIR's dedicated IR Residency web page.

Match Update—219 New IR Fellows-in-Training

June 19 was match day for vascular and interventional radiology fellowship programs for the 2014 appointment year. In the match, 227 fellowship positions were offered with 219 filled and 8 unfilled for a 96.5 percent fill rate. Over the last 6 years, there has been a steady increase in the ratio of applicants per position offered in the match. This may indicate a continued upswing in trainee interest in interventional radiology (there were 89 IR fellows matched in 2008).
As of this year, there are 92 Accreditation Council for Graduate Medical Education (ACGME)–accredited interventional radiology fellowships. (Interventional radiology has 11 programs not participating in the match for which there is no data.)

IR Store

Please download the SIR 2015 Publications Catalog for a complete listing of SIR materials and publications that can be purchased and used to enhance relationships with your IR customers. To see all Society products, visit the IR Store.

SIR Foundation Discovery Campaign

SIR Foundation is the mechanism through which we seek to establish the safety and efficacy of IR. Its Discovery Campaign was a major fund raising initiative to further minimally invasive medicine into new areas of discovery. We are pleased to announce that industry supported generously with more than $3 million raised in this strengthened commitment to research ensuring that IR remains at the front line of innovation. While the Discovery Campaign’s fundraising phase has concluded, contact the SIR Foundation to learn about the many opportunities for your company to keep the pioneering nature of IR alive, vibrant and expanding.


To learn more, email Corporate Relations Department.